D. Wagner (Lund, Sweden), O. Burgy (Dijon, France)
Late Breaking Abstract - Aminopeptidase N/CD13 distinguishes two populations of colony-forming mesenchymal stromal cells in human lung tissue
M. Kadefors (Lund, Sweden), S. Rolandsson Enes (Lund, Sweden), M. Weitoft (Lund, Sweden), S. Scheding (Lund, Sweden), G. Westergren-Thorsson (Lund, Sweden)
|     |
Late Breaking Abstract - Myeloid-derived microvesicles as acute mediators of sepsis-induced lung vascular inflammation
D. Tsiridou (London, United Kingdom), K. O'Dea (London, United Kingdom), Y. Tan (London, United Kingdom), M. Takata (London, United Kingdom)
| |
Blocking Focal adhesion kinase (FAK) protects against damage in a novel model of lymphocyte dominant lung injury
D. Brister (Calgary, Canada), G. Aulakah (Saskatoon, Canada), H. Zhang (Calgary, Canada), K. Patel (Calgary, Canada)
| |
A humanized animal model of pulmonary fibrosis based on cellular senescence
F. Hernandez Gonzalez (Barcelona, Spain), F. Pietrocola (Barcelona, Spain), N. Prats (Barcelona, Spain), K. Meyer (Barcelona, Spain), J. Lopez-Dominguez (Barcelona, Spain), M. Muñoz (Barcelona, Spain), M. Rovira (Barcelona, Spain), D. Martinez (Barcelona, Spain), J. Ramirez (Barcelona, Spain), A. Agusti (Barcelona, Spain), R. Faner (Barcelona, Spain), J. Sellares (Barcelona, Spain), M. Serrano (Barcelona, Spain)
| |
High-plex immunofluorescence single cell analysis of fibrotic murine lung on tissue microarrays
F. Ravanetti (Parma, Italy), R. Ciccimarra (Parma, Italy), M. Bolognesi (Monza, Italy), F. Ruscitti (Parma, Italy), L. Ragionieri (Parma, Italy), G. Cattoretti (Monza, Italy), G. Villetti (Parma, Italy), F. Stellari (Parma, Italy)
| |
The role of resident lung mesenchymal stromal cells in normal and aberrant lung development
I. Mizikova (Ottawa, Canada), C. Cyr-Depauw (Ottawa, Canada), F. Lesage (Ottawa, Canada), M. Hurskainen (Ottawa, Canada), A. Vadivel (Ottawa, Canada), S. Zhong (Ottawa, Canada), B. Thèbaud (Ottawa, Canada)
| |
Inflammatory microenvironment in both healthy controls and ARDS patients polarize clinically utilized MSCs towards a pro-inflammatory MSC phenotype
S. Rolandsson Enes (Lund, Sweden), T. H. Hampton (Hanover, United States of America), D. H. Mckenna (Minnesota, United States of America), C. C. Dos Santos (Toronto, Canada), K. D. Liu (San Francisco, United States of America), B. A. Stanton (Hanover, United States of America), P. R. M. Rocco (Rio de Janeiro, Brazil), M. A. Matthay (San Francisco, United States of America), D. J. Weiss (Burlington, United States of America)
| |
High-dimensional mass cytometry analysis of immune cells in emphysematous lung tissue
P. Khedoe (Leiden, Netherlands), N. Li (Leiden, Netherlands), L. Jia (Leiden, Netherlands), N. Guo (Leiden, Netherlands), P. Hiemstra (Leiden, Netherlands), F. Koning (Leiden, Netherlands), J. Stolk (Leiden, Netherlands)
| |